A Practical Approach To Cardiac Anesthesia

Getting Through The Case Without Something Terrible Happening

Cardiac anesthesia is less about mastering a single technique and more about managing a situation where the margin between catastrophe can be measured in milliliters of blood or seconds of cross-clamp time. I started doing these cases around 2012, and the short version is that most of the disasters I saw in my early years came from people who understood the pharmacology but not the hemodynamics. Or vice versa. Let me just walk through what actually matters in practice. The core problem with cardiac anesthesia is that the physiology is continuously shifting under your feet. You induce a patient with severe aortic stenosis, and suddenly they are hypotensive. You induce a patient with severe mitral regurgitation, and now their pulmonary pressures are climbing. The textbook answers don't always apply in the operating room because the textbook assumes stable baseline conditions, and cardiac patients almost never have stable baseline conditions. What works is having a mental model of what each drug does to preload, afterload, contractility, and heart rate, then applying that model in real time as the surgical team manipulates the heart. For induction, etomidate remains the workhorse for a reason. It is hemodynamically neutral in most doses, and that neutrality matters when you are about to crack a chest. Propofol can work, but you need to dose it more conservatively than you would for a routine case. Fentanyl at 10 to 20 mcg/kg is standard, though I have seen patients with critical aortic stenosis drop their blood pressure into the basement on even modest doses of fentanyl. In those cases, I often go with a lower opioid dose and supplement with a small bolus of phenylephrine before induction. The key is to think of induction as a sequence of small, controlled perturbations rather than one big event.

Maintaining anesthesia during sternotomy and cannulation is where most residents get tripped up. You want adequate depth to blunt the sympathetic response to bone saw vibration and pericardial traction, but you also need the patient to have reasonable vasoconstriction so that vasodilation from deeper anesthesia does not compromise coronary perfusion pressure. This is a balancing act that varies case by case. In a patient with three-vessel disease and a left ventricular ejection fraction of 30 percent, I am generally happier running lighter anesthesia with more vasopressor support than I am running deep anesthesia with less pressor. The myocardium needs adequate perfusion pressure above all else during this phase. Once cardiopulmonary bypass is initiated, the game changes completely. The anesthesiologist is no longer managing native cardiac output. You are managing the pump flow, hematocrit, temperature, and coagulation. The most common mistake I see on bypass is focusing exclusively on the pump parameters and forgetting about the patient's metabolic state. A patient who is significantly hypothermic at 28 degrees Celsius will have prolonged coagulation times that have nothing to do with the heparin administration and everything to do with cold-induced platelet dysfunction. Warming strategies matter, but so does accepting that some bleeding is physiologic at low temperatures and does not necessarily indicate a coagulopathy that needs massive transfusion. Let me give you a specific example from my own practice. I had a patient several years ago undergoing elective CABG who developed acute right ventricular failure immediately upon weaning from bypass. The standard approach would have been to increase inotropic support with milrinone and epinephrine. But I noticed that the RV was dilated with a flat interventricular septum, which suggested the problem was not primarily contractile. It was afterload. The pulmonary vascular resistance was elevated, likely from chronic lung disease. Milrinone would have systemically vasodilated and potentially worsened the situation by dropping systemic blood pressure while the pulmonary resistance stayed high. I switched to inhaled nitric oxide for selective pulmonary vasodilation and added a small dose of epinephrine for inotropic support. The RV recovered within twenty minutes. This is the kind of case where a recipe-book approach fails you.

Dealing with cardioplegia is another area where nuances matter. The temperature of the cardioplegia solution, the timing of administration, and the choice between antegrade and retrograde delivery all affect myocardial protection. I tend to favor cold blood cardioplegia delivered antegradely for most cases because it provides better oxygen delivery to the myocardium during the cross-clamp period. However, if the aorta is heavily calcified or there is significant aortic regurgitation, antegrade delivery becomes impractical and you need to consider alternative strategies. There is no universal answer here. You assess the anatomy and choose accordingly. Post-bypass management is where the rubber meets the road. The transition from bypass to native cardiac function requires careful attention to volume status, inotropic support, and arrhythmia prevention. I usually start weaning by ensuring the patient is adequately volume loaded, since the heart on bypass has been unloaded for hours and the ventricles need preload to generate meaningful cardiac output. A fluid bolus of 250 to 500 milliliters is often enough to make the difference between a successful emergence and a prolonged low-output state. Then I introduce inotropic support as needed. Dobutamine at 2.5 to 10 mcg/kg/min is my starting point for most patients. Milrinone is useful in patients with elevated pulmonary vascular resistance or those who are already on chronic beta-blockers, but it has a longer half-life and can cause prolonged hypotension, so I tend to reserve it for specific situations rather than using it routinely. One counter-intuitive point that beginners consistently miss is the relationship between heart rate and diastolic filling time in post-bypass patients. A faster heart rate is not automatically bad. In fact, a moderately elevated heart rate can be beneficial in patients with poor ventricular compliance because it reduces diastolic filling time and can actually improve coronary perfusion by keeping the heart smaller and less tense. The instinct to aggressively treat sinus tachycardia with beta-blockers after cardiac surgery is often wrong. Treat the underlying cause. If the tachycardia is compensatory for low cardiac output, a beta-blocker will make things worse. If it is sinus node dysfunction or atrial tachycardia, then rate control makes sense. The distinction matters enormously.

Another pitfall is over-reliance on transesophageal echo without correlating it with invasive hemodynamic data. TEE is an invaluable tool, but it is not infallible. I have seen cases where the TEE image suggested adequate ventricular function while the arterial line told a very different story. Always cross-reference. If the TEE says the heart looks fine but the blood pressure is crashing, trust the blood pressure first and investigate why there is a discrepancy rather than assuming the image is correct. There are also scenarios where cardiac anesthesia simply cannot save the patient no matter what you do. Severe primary pulmonary hypertension is one of them. These patients tolerate bypass poorly, wean extremely poorly, and have very limited pharmacological options that do not simultaneously compromise systemic perfusion. In these cases, the best approach is often prevention rather than treatment. Maintaining systemic blood pressure with vasopressors before and during bypass, avoiding hypoxia and hypercarbia, and having inhaled nitric oxide or epoprostenol readily available can make the difference. But if the pulmonary vascular resistance is fixed and severe, even the most skilled anesthesiologist will struggle. Acknowledging this limitation early and discussing it with the surgical team can prevent wasted effort and futile interventions. For patients undergoing valve surgery rather than CABG, the hemodynamic goals shift. Aortic valve replacement in a patient with severe AS requires maintaining sinus rhythm, adequate preload, and systemic vascular resistance. Tachycardia is poorly tolerated because it reduces diastolic filling time in a ventricle that is already hypertrophied and stiff. Bradycardia is also problematic because the fixed obstruction means stroke volume cannot increase to compensate. The ideal heart rate in this setting is somewhere in the low to mid 70s. For mitral valve surgery, the priorities are different. Volume management is critical because the left ventricle is often underfilled chronically, and aggressive volume administration can suddenly unload a ventricle that has been operating on the flat portion of the Frank-Starling curve. A moderate fluid challenge followed by careful hemodynamic assessment is more reliable than bolusing freely.

The documentation and communication aspects of cardiac anesthesia are often underestimated but they have real clinical consequences. Writing down the heparin dose, the activated clotting time, the cardioplegia volumes and times, and the blood product administration creates a timeline that is invaluable when complications arise. I learned this the hard way during a case where the patient developed diffuse oozing after protamine reversal. Without precise records of when each unit of blood and each dose of coagulation factor was given, it was nearly impossible to determine whether the coagulopathy was dilutional, consumption-based, or protamine-related. The turnaround was probably twenty minutes, but those twenty minutes matter when the patient is bleeding out. If you are looking for resources to deepen your understanding, the classic textbooks like Kaplan's Cardiac Anesthesia and Pugsley's Core Curriculum in Cardiac Anesthesia remain the standard references. They are dense and not always easy to read cover to cover, but they are comprehensive. Online resources like the Society of Cardiovascular Anesthesiologists have practice guidelines that are freely available and surprisingly useful for quick reference. YouTube channels with intraoperative TEE recordings can also be helpful for visual learners, though the quality of content varies widely. The reality of cardiac anesthesia is that it is technically demanding, physiologically complex, and emotionally draining. The good cases are quietly uneventful and go unremarked. The bad cases are unforgettable. The goal is not to eliminate bad cases entirely, because that is impossible, but to minimize the number of cases where preventable errors contribute to poor outcomes. That requires constant vigilance, a willingness to admit when you do not know something, and the humility to ask for help before the situation becomes unrecoverable. Most of the senior anesthesiologists I respect are the ones who are most comfortable saying they do not know, not the ones who pretend to have all the answers.